Naunyn-Schmiedeberg's archives of pharmacology

Global research trends on brain-protecting drugs for neurodegenerative diseases from 2006 to 2025

Updated

Abstract

A total of 1,202 publications on glucagon-like peptide-1 receptor agonists in neurodegenerative diseases were identified, with annual output increasing from 2 in 2006 to 241 in 2025.

  • The research output significantly accelerated after 2020.
  • China, the USA, and England are identified as the leading contributors and collaboration hubs in this field.
  • Key institutions include Shanxi Medical University, Lancaster University, and the National Institute on Aging.
  • Major journals publishing related work include the International Journal of Molecular Sciences and Journal of Alzheimer's Disease.
  • Keyword and citation analyses reveal a thematic shift from older topics to newer ones like semaglutide and neuroinflammation.
  • The field has transitioned from preclinical studies to increased focus on clinical research and therapeutic approaches.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declarations. Generative AI statement: Acknowledging the use of artificial intelligence-assisted tools for language polishing and grammatical refinement, the authors confirm that such tools were applied exclusively for improving linguistic clarity. All substantive academic content, analyses, and interpretations remain the sole responsibility of the authors. Clinical resources: No specific clinical resources websites applicable to this article are included. Ethics declaration: Ethical approval was not required for this work as it did not involve human or animal subjects. No data collection from human participants or animals occurred. Consent to publish: All authors listed above have reviewed the final version of this manuscript and consent to its submission for publication. We affirm that this work is original, has not been published previously, and is not under consideration elsewhere. If accepted, all authors approve its publication in its present form and will grant the Journal an exclusive license to publish the article. Consent to participate: This Declaration does not apply. Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free